Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00305357 · ClinicalTrials.gov registry record

Evolution of Pain From Herpes Zoster

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
100
Enrollment target

NCT00305357: Completed study, sponsored by University of California, San Francisco.

NCT00305357 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00305357 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

Evolution of pain and neural injury will be evaluated at 2 years or longer after the onset of AHZ by multiple measures. Assessments at 2 years or longer will be compared to those collected during the first 6 months after HZ in order to test whether or not sensory function and cutaneous innervation continues to normalize beyond 6 months in subjects who recover from HZ without severe PHN.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2001-11
Est. Completion 2006-12

What the finished NCT00305357 record still lists

NCT00305357 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00305357 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00305357 about?

NCT00305357 is a clinical study titled "Evolution of Pain From Herpes Zoster". Evolution of pain and neural injury will be evaluated at 2 years or longer after the onset of AHZ by multiple measures. Assessments at 2 years or longer will be compared to those collected during the first 6 months after HZ in order to test whether or not sensory function and cutaneous innervation c...

What is the current status of trial NCT00305357?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2001-11. Estimated completion is 2006-12.

Who is sponsoring clinical trial NCT00305357?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00305357, the US trial registry maintained by the National Library of Medicine. NCT00305357 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.